Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

79.36USD
4:00pm EDT
Price Change (% chg)

$0.63 (+0.80%)
Prev Close
$78.73
Open
$78.80
Day's High
$79.43
Day's Low
$78.72
Volume
939,644
Avg. Vol
771,411
52-wk High
$81.13
52-wk Low
$66.83

DHR.N

Chart for DHR.N

About

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company’s research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. It operates in five segments: Test &... (more)

Overall

Beta: 1.15
Market Cap (Mil.): $55,164.86
Shares Outstanding (Mil.): 700.68
Dividend: 0.10
Yield (%): 0.51

Financials

  DHR.N Industry Sector
P/E (TTM): 21.27 24.35 30.98
EPS (TTM): 3.70 -- --
ROI: 8.80 9.25 7.72
ROE: 12.01 10.97 11.28
Search Stocks

Danaher to buy Nobel Biocare for $2.2 billion

ZURICH - U.S. healthcare group Danaher Corp is to buy Nobel Biocare Holding AG for an agreed $2.2 billion to become the world's biggest player in a dental implants market benefiting from growing demand for cosmetic dentistry.

15 Sep 2014

UPDATE 4-Danaher to buy Nobel Biocare for $2.2 bln

* Deal to make Danaher world No.1 maker of dental implants

15 Sep 2014

BRIEF-Nobel Biocare shares open down 5.8 percent

Sept 15 - Nobel Biocare : * Nobel biocare shares open down 5.8 percent after Danaher agrees to buy

15 Sep 2014

Swiss stocks - Factors to watch on Sept 15

ZURICH, Sept 15 - Swiss shares were seen opening lower on Monday, in line with European shares, after disappointing data from China raised fresh concerns about the pace of economic growth in the world's second-biggest economy.

15 Sep 2014

BRIEF-Nobel Biocare seen opening down 3.3 pct - premarket

Sept 15 - NOBELBIOCARE/ * Shares in Nobel Biocare seen opening down 3.3 percent after Danaher agrees to

15 Sep 2014

Danaher to buy Nobel Biocare Holding for $2.2 billion including debt

Sept 15 - U.S. healthcare conglomerate Danaher Corp said it will buy Nobel Biocare Holding in an all-cash deal valued at about $2.2 billion, including debt, to widen its market presence in the global dental industry.

15 Sep 2014

UPDATE 1-Market Chatter-Corporate finance press digest

Aug 12 - The following corporate finance-related stories were reported by media:

12 Aug 2014

Market Chatter- Corporate finance press digest

Aug 12 - The following corporate finance-related stories were reported by media:

12 Aug 2014

Deals of the day- Mergers and acquisitions

(Adds Cutrale, Kommunalkredit, Superior Energy, SAIL, ValueAct Capital, Banca Popolare, MOL, Bunge Ltd; updates Kinder Morgan)

11 Aug 2014

Nobel Biocare said to attract takeover interest -Bloomberg

LONDON/ZURICH, Aug 11 - Swiss dental-implant maker Nobel Biocare has attracted interest from possible buyers including U.S. conglomerate Danaher Corp and buyout group EQT Partners, Bloomberg reported on Monday, citing people with knowledge of the matter.

11 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks